
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Oct 31, 2025 06:54 am UTC| Business Health
Eli Lilly announced that its experimental weight-loss pill, orforglipron, meets most of the criteria for the U.S. Food and Drug Administrations (FDA) new national priority voucher, positioning it for potentially...

Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Oct 26, 2025 23:29 pm UTC| Business Health
Swiss pharmaceutical giant Novartis has announced a definitive agreement to acquire U.S.-based biotech firm Avidity Biosciences for approximately $12 billion in cash, marking another major step in its expansion into the...

Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Oct 19, 2025 00:59 am UTC| Business Health Politics
Novo Nordisk has named U.S. pharmaceutical executive Greg Miley as its new Global Head of Corporate Affairs, a strategic move as the Danish drugmaker faces heightened scrutiny from U.S. President Donald Trump over drug...

Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Oct 18, 2025 02:34 am UTC| Business Health Politics
Novo Nordisk has named U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, a move aimed at strengthening its political and public relations strategy as President Donald Trump intensifies pressure...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Oct 17, 2025 01:07 am UTC| Politics Business Health Science Economy
U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...

Oct 13, 2025 08:40 am UTC| Business Health
Pharmaceutical giants are pivoting toward direct-to-consumer sales and offering steep drug discounts in the United States after President Donald Trump called for lower prescription prices and reduced reliance on middlemen...

FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Oct 13, 2025 02:34 am UTC| Health Business Science
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy developed by Johnson Johnson and Legend Biotech, to include a warning about a rare but potentially...